156 related articles for article (PubMed ID: 27966518)
1. Impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma.
Wagner VP; Ortiz L; da Silva HP; Meurer L; da Cunha Filho JJ; Martins MA; Martins MD
Indian J Dent Res; 2016; 27(5):559-562. PubMed ID: 27966518
[TBL] [Abstract][Full Text] [Related]
2. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.
Lester R; Li C; Phillips P; Shenkier TN; Gascoyne RD; Galbraith PF; Vickars LM; Leitch HA
Leuk Lymphoma; 2004 Sep; 45(9):1881-5. PubMed ID: 15223650
[TBL] [Abstract][Full Text] [Related]
4. Oral plasmablastic lymphoma: A case report.
Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients.
Mai B; Wang W; Lin M; Hu S; Wang XI; Chen L; Wahed A; Nguyen A; Ma HY; Medeiros LJ; Hu Z
AIDS; 2020 Oct; 34(12):1735-1743. PubMed ID: 32889849
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy.
Francischini E; Martins FM; Braz-Silva PH; Magalhães MH; Ortega KL
Int J STD AIDS; 2010 Jan; 21(1):68-70. PubMed ID: 19884361
[TBL] [Abstract][Full Text] [Related]
7. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
[TBL] [Abstract][Full Text] [Related]
9. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.
Noy A; Lensing SY; Moore PC; Gupta N; Aboulafia D; Ambinder R; Baiocchi R; Dezube BJ; Henry D; Kaplan L; Levine AM; Mitsuyasu R; Ratner L; Reid E; Remick S; Sparano J; Tzachanis D; Wachsman W; Chadburn A
Leuk Lymphoma; 2016 Jul; 57(7):1731-4. PubMed ID: 26674561
[No Abstract] [Full Text] [Related]
10. Dramatic treatment response of cutaneous plasmablastic lymphoma in an HIV patient: a case report.
Sakib SM; Sadler M
Clin Imaging; 2016; 40(6):1067-1069. PubMed ID: 27408991
[TBL] [Abstract][Full Text] [Related]
11. Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report.
Vieira FO; El Gandour O; Buadi FK; Williams GB; Shires CB; Zafar N
Head Neck Pathol; 2008 Jun; 2(2):92-6. PubMed ID: 20614329
[TBL] [Abstract][Full Text] [Related]
12. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.
Nasta SD; Carrum GM; Shahab I; Hanania NA; Udden MM
Leuk Lymphoma; 2002 Feb; 43(2):423-6. PubMed ID: 11999580
[TBL] [Abstract][Full Text] [Related]
13. Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection.
Riedel DJ; Gonzalez-Cuyar LF; Zhao XF; Redfield RR; Gilliam BL
Lancet Infect Dis; 2008 Apr; 8(4):261-7. PubMed ID: 18353267
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.
Rhoades R; Gong J; Palmisiano N; Alpdogan O
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30872336
[TBL] [Abstract][Full Text] [Related]
16. Plasmablastic lymphoma of the oral cavity with breast recurrence: a case report.
Samoon Z; Idrees R; Masood N; Ansari TZ
BMC Res Notes; 2015 May; 8():180. PubMed ID: 25933603
[TBL] [Abstract][Full Text] [Related]
17. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations.
Flaitz CM; Nichols CM; Walling DM; Hicks MJ
Oral Oncol; 2002 Jan; 38(1):96-102. PubMed ID: 11755827
[TBL] [Abstract][Full Text] [Related]
18. Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone.
Koszyk-Szewczyk A; Bayerl M; Zurlo J; Drabick JJ
South Med J; 2010 Jan; 103(1):76-80. PubMed ID: 19996843
[TBL] [Abstract][Full Text] [Related]
19. Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity.
Mota F; Mesquita B; Carvalho S; Coelho A; Velho G; Lima M; Selores M
Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617520
[TBL] [Abstract][Full Text] [Related]
20. Relationship between oral Kaposi 's sarcoma and HAART: contribution of two case reports.
Campo-Trapero J; Del Romero-Guerrero J; Cano-Sánchez J; Rodríguez-Martín C; Martínez-González JM; Bascones-Martínez A
Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E709-13. PubMed ID: 18978711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
